Sartorius Stedim Biotech S.A.
SRTOY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18,364 | $22,871 | $26,682 | $35,269 |
| - Cash | $679 | $117 | $107 | $224 |
| + Debt | $2,870 | $3,682 | $1,136 | $626 |
| Enterprise Value | $20,555 | $26,436 | $27,711 | $35,671 |
| Revenue | $2,780 | $2,776 | $3,493 | $2,887 |
| % Growth | 0.2% | -20.5% | 21% | – |
| Gross Profit | $1,207 | $1,234 | $1,835 | $1,553 |
| % Margin | 43.4% | 44.4% | 52.5% | 53.8% |
| EBITDA | $671 | $756 | $1,331 | $812 |
| % Margin | 24.1% | 27.2% | 38.1% | 28.1% |
| Net Income | $175 | $310 | $876 | $414 |
| % Margin | 6.3% | 11.2% | 25.1% | 14.4% |
| EPS Diluted | 0.18 | 0.34 | 0.95 | 0.45 |
| % Growth | -47.1% | -64.2% | 111.1% | – |
| Operating Cash Flow | $815 | $630 | $612 | $696 |
| Capital Expenditures | -$340 | -$474 | -$431 | -$324 |
| Free Cash Flow | $475 | $156 | $182 | $372 |